Journal of Bioethical Inquiry

, Volume 7, Issue 1, pp 13-29

First online:

From Evidence-based Medicine to Marketing-based Medicine: Evidence from Internal Industry Documents

  • Glen I. SpielmansAffiliated withDepartment of Psychology, Metropolitan State University Email author 
  • , Peter I. ParryAffiliated withDepartment of Psychiatry, Flinders University

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


While much excitement has been generated surrounding evidence-based medicine, internal documents from the pharmaceutical industry suggest that the publicly available evidence base may not accurately represent the underlying data regarding its products. The industry and its associated medical communication firms state that publications in the medical literature primarily serve marketing interests. Suppression and spinning of negative data and ghostwriting have emerged as tools to help manage medical journal publications to best suit product sales, while disease mongering and market segmentation of physicians are also used to efficiently maximize profits. We propose that while evidence-based medicine is a noble ideal, marketing-based medicine is the current reality.


Evidence-based medicine Marketing Marketing-based medicine Pharmaceutical industry Olanzapine Quetiapine